Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies' motion to amend its complaint in a lawsuit it filed against Twist Bioscience in 2016 was granted, according to documents Twist filed today with the US Securities and Exchange Commission.

The Santa Clara Superior Court also denied Agilent's motion to limit the discovery that Twist and Twist CEO Emily Leproust could seek in the case and set a date for the trial of Feb. 24, 2020.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.